Document:

EX-10.1

 Exhibit 10.1 
  

			
	

	  	 3400 Bridge Parkway
 Redwood Shores,
CA 94065
 Tel: +1 (650) 345-9000
 Fax: +1 (650)
240-0500
 www.imperva.com

 August 13, 2014 

Anthony Bettencourt 
 Dear Anthony: 

Imperva, Inc. (the “Company”) is pleased to offer you employment on the following terms: 

1. Position. Your title will be President and Chief Executive Officer and you will report to the Company’s Board of Directors (the
“Board”). This is a full-time position based out of the Company’s headquarters in Redwood Shores, California. While you are employed at the Company, you will abide by your duty of loyalty to the Company, will perform your duties and
follow the lawful directions of the Board in a diligent manner, and will devote your full time, energy and attention to the interests of the Company. By signing this letter agreement, you confirm to the Company that you have no contractual
commitments or other legal obligations that would prohibit you from performing your duties for the Company. 
 2. Cash Compensation. The Company will
pay you a starting salary at the rate of $31,250 per month ($375,000 per year), payable in accordance with the Company’s standard payroll schedule. This salary will be subject to adjustment pursuant to the Company’s employee compensation
policies in effect from time to time. In addition, you will be eligible to participate in the Company’s bonus plan as in effect from time to time. Initially, your annual bonus goal will be $375,000 (100% of base salary) at target and paid
quarterly in accordance with the Company’s 2014 Management Bonus Plan. Changes in your compensation from time to time will be determined by the Compensation Committee of the Board. It is expected that your base salary, bonus and other
compensation will be reviewed again in connection with the Compensation Committee’s standard review for 2015 executive compensation (anticipated to commence in the fourth quarter of 2014 and be finalized in the first quarter of 2015). 

3. Equity. The Company shall, subject to the approval of its Board of Directors or a committee of the Board of Directors, grant to you (a) a stock
option to purchase 265,000 shares of Common Stock of the Company (the “Option”) and (b) restricted stock units for 265,000 shares of Common Stock of the Company (the “RSUs”). The Option will have an exercise price equal to
the closing price of our common stock on the New York Stock Exchange on its grant date. The Option will commence vesting on your employment start date and the RSUs will commence vesting on November 15, 2014 (provided that your start date is
prior to then). The Option and 

  
  

 

			
	Confidential Offer Letter – <name>	  	Page 1

 
the RSUs will vest and become exercisable with respect to 25% of the shares subject to it on the first anniversary of their respective vesting commencement dates with an additional 6.25% of the
shares in such grants vesting each quarter thereafter so long as you remain continuously employed by the Company as an employee, in each case subject to the terms of the Company’s Change in Control Plan (as filed on EDGAR with the Securities
and Exchange Commission). The specific terms and conditions of the equity grants will be set forth in a separate Option Agreement and a separate Restricted Stock Unit Agreement that shall supersede the similar terms hereof. Those agreements are
expected not to be made under the Company’s 2011 Stock Option and Incentive Plan, but are expected to have substantially similar effective terms and conditions to grants made under the plan subject to its terms. 

4. Employee Benefits. As a regular employee of the Company, you will be eligible to participate in a number of Company-sponsored benefits as in effect
from time to time. In addition, you will be entitled to paid vacation in accordance with the Company’s vacation policy, as in effect from time to time. 

5. Proprietary Information and Inventions Agreement. Like all Company employees, you will be required, as a condition of your employment with the
Company, to sign the Company’s standard Proprietary Information and Inventions Agreement, a copy of which is attached hereto as Exhibit A. 
 6.
Employment Relationship. Employment with the Company is for no specific period of time. Your employment with the Company will be “at will,” meaning that either you or the Company may terminate your employment at any time and for any
reason, with or without cause. Any contrary representations that may have been made to you are superseded by this letter agreement. This is the full and complete agreement between you and the Company on this term. Although your job duties, title,
compensation and benefits, as well as the Company’s personnel policies and procedures, may change from time to time, the “at will” nature of your employment may only be changed in an express written agreement signed by you and the
Company’s Chief Executive Officer. 
 7. Outside Activities. While you render services to the Company, you agree that you will not engage in any
other employment, consulting or other business activity without the prior written consent of the Company. While you render services to the Company, you also will not assist any person or entity in competing with the Company, in preparing to compete
with the Company or in hiring any employees or consultants of the Company. 
 8. Withholding Taxes. All forms of compensation referred to in this
letter agreement are subject to reduction to reflect applicable withholding and payroll taxes and other deductions required by law. 
 9. Proof of
Employment Eligibility and Background Check. This offer is contingent upon your completion and execution of all employment documents, as well as your ability to provide proof of identification and authorization to work in the United States
(within two business days of your start date) and upon passing the Company’s mandatory background verification, even if this information is not known until after your employment commences. 

  
  

 

			
	Confidential Offer Letter – <name>	  	Page 2

 10. Board Membership. In connection with your appointment as President and Chief Executive Officer, it is
anticipated that you will also be elected as a member of the Board. 
 11. Indemnification. You will receive an indemnification agreement for your
service as an officer and director of the Company consistent with indemnification agreements in place with other executive officers of the Company. 
 12.
Miscellaneous. This Agreement, the Company’s Change in Control Plan and Exhibit A supersede and replace any prior agreements, representations or understandings (whether written, oral, implied or otherwise) between you and the
Company and constitute the complete agreement between you and the Company regarding the subject matter set forth herein. This Agreement may not be amended or modified, except by an express written agreement signed by both you and an authorized
representative of the Board. Unless otherwise requested in writing by the Company’s Board of Directors, on the termination of your employment with the Company for any reason, not later than the date of such termination, you hereby resign and
agree to resign effective as of the date of such termination as an officer of the Company (including any and all titles in such capacity) and from any and all officerships, directorships or fiduciary positions with the Company or its affiliates. You
agree to provide at such time a separate written resignation in customary form reasonably acceptable to the General Counsel of the Company; it being understood that the effectiveness of the foregoing sentence does not depend upon delivery of such
separate document. 
 ********** 

  
  

 

			
	Confidential Offer Letter – <name>	  	Page 3

 We hope that you will accept our offer to join the Company. You may indicate your agreement with these terms and
accept this letter agreement by signing and dating both the enclosed duplicate original of this letter agreement and the enclosed Proprietary Information and Inventions Agreement and returning them to me. This offer, if not accepted, will expire at
the close of business on August 15, 2014. Your employment is also contingent upon your starting work with the Company on or before September 3, 2014. 

 

			
	Very truly yours,
	
	IMPERVA, INC.
		
	By:	 	 /s/ Frank Slootman

		 	Frank Slootman
		
	Title:	 	Chairman of the Compensation Committee
		
	Dated:	 	 8-13-14

  

			
	I have read and accept this employment offer:
	
	 /s/ Anthony Bettencourt

	Signature of Anthony Bettencourt

			
		
	Dated:	 	 8-13-14

 Attachment 
 Exhibit A:
Proprietary Information and Inventions Agreement 

 PROPRIETARY INFORMATION AND INVENTION AGREEMENT 

In consideration of, and as a condition of my employment with Imperva, Inc., a Delaware corporation (the “Company”),
I, as the “Employee” signing this Proprietary Information and Invention Agreement (this “Agreement”), hereby represent to the Company, and the Company and I hereby agree as follows: 

1. Purpose of Agreement. I understand that the Company is engaged in a continuous program of research, development, production
and/or marketing in connection with its current and projected business and that it is critical for the Company to preserve and protect its proprietary information, its rights in certain inventions and works and in related intellectual property
rights. Accordingly, I am entering into this Agreement, whether or not I am expected to create inventions or other works of value for the Company. As used in this Agreement, “Inventions” means inventions, improvements,
designs, original works of authorship, formulas, processes, compositions of matter, computer software programs, databases, mask works, confidential information and trade secrets. 

2. Disclosure of Inventions. I will promptly disclose in confidence to the Company, or to any person designated by it, all
Inventions that I make, create, conceive or first reduce to practice, either alone or jointly with others, during the period of my employment, whether or not in the course of my employment, and whether or not patentable, copyrightable or protectable
as trade secrets. 
 3. Work for Hire; Assigned Inventions. I acknowledge and agree that any copyrightable works prepared by
me within the scope of my employment will be “works made for hire” under the Copyright Act and that the Company will be considered the author and owner of such copyrightable works. I agree that all Inventions that I make, create, conceive
or first reduce to practice during the period of my employment, whether or not in the course of my employment, and whether or not patentable, copyrightable or protectable as trade secrets, and that (i) are developed using equipment, supplies,
facilities or trade secrets of the Company; (ii) result from work performed by me for the Company; or (iii) relate to the Company’s business or actual or demonstrably anticipated research or development (the “Assigned
Inventions”), will be the sole and exclusive property of the Company. 
 4. Excluded Inventions and Other
Inventions. Attached hereto as Exhibit A is a list describing all existing Inventions, if any, that may relate to the Company’s business or actual or demonstrably anticipated research or development and that were made by me
or acquired by me prior to the Effective Date (as defined in Section 25, below), and which are not to be assigned to the Company (“Excluded Inventions”). If no such list is attached, I represent and agree that it is
because I have no rights in any existing Inventions that may relate to the Company’s business or actual or demonstrably anticipated research or development. For purposes of this Agreement, “Other Inventions” means
Inventions in which I have or may have an interest, as of the Effective Date or thereafter, other than Assigned Inventions and Excluded Inventions. I acknowledge and agree that if, in the scope of my employment, I use any Excluded Inventions or any
Other Inventions, or if I include any Excluded Inventions or Other Inventions in any product or service of the Company or if my rights in any Excluded Inventions or Other Inventions may block or interfere with, or may otherwise be required for, the
exercise by the Company of any 

 
rights assigned to the Company under this Agreement, I will immediately so notify the Company in writing. Unless the Company and I agree otherwise in writing as to particular Excluded Inventions
or Other Inventions, I hereby grant to the Company, in such circumstances (whether or not I give the Company notice as required above), a perpetual, irrevocable, nonexclusive, transferable, world-wide, royalty-free license to use, disclose, make,
sell, offer for sale, import, copy, distribute, modify and create works based on, perform, and display such Excluded Inventions and Other Inventions, and to sublicense third parties in one or more tiers of sublicensees with the same rights. 

5. Exception to Assignment. I understand that the Assigned Inventions will not include, and the provisions of this Agreement
requiring assignment of inventions to the Company do not apply to, any invention that qualifies fully for exclusion under the provisions of Section 2870 of the California Labor Code, which are attached hereto as Exhibit B. 

6. Assignment of Rights. I agree to assign, and do hereby irrevocably transfer and assign, to the Company: (i) all of my
rights, title and interests in and with respect to any Assigned Inventions; (ii) all patents, patent applications, copyrights, mask works, rights in databases, trade secrets, and other intellectual property rights, worldwide, in any Assigned
Inventions, along with any registrations of or applications to register such rights; and (iii) to the extent assignable, any and all Moral Rights (as defined below) that I may have in or with respect to any Assigned Inventions. I also hereby
forever waive and agree never to assert any Moral Rights I may have in or with respect to any Assigned Inventions and any Excluded Inventions or Other Inventions licensed to the Company under Section 4, even after termination of my employment
with the Company. “Moral Rights” means any rights to claim authorship of a work, to object to or prevent the modification or destruction of a work, to withdraw from circulation or control the publication or
distribution of a work, and any similar right, regardless of whether or not such right is denominated or generally referred to as a “moral right.”  

7. Assistance. I will assist the Company in every proper way to obtain and enforce for the Company all patents, copyrights, mask
work rights, trade secret rights and other legal protections for the Assigned Inventions, worldwide. I will execute and deliver any documents that the Company may reasonably request from me in connection with providing such assistance. My
obligations under this section will continue beyond the termination of my employment with the Company; provided that the Company agrees to compensate me at a reasonable rate after such termination for time and expenses actually spent by me at
the Company’s request in providing such assistance. I hereby appoint the Secretary of the Company as my attorney-in-fact to execute documents on my behalf for this purpose. I agree that this appointment is coupled with an interest and will not
be revocable. 
 8. Proprietary Information. I understand that my employment by the Company creates a relationship of
confidence and trust with respect to any information or materials of a confidential or secret nature that may be made, created or discovered by me or that may be disclosed to me by the Company or a third party in relation to the business of the
Company or to the business of any parent, subsidiary, affiliate, customer or supplier of the Company, or any other party with whom the Company agrees to hold such information or materials in confidence (the “Proprietary
Information”). Without limitation as to the forms that Proprietary Information may take, I acknowledge that Proprietary Information may be contained in tangible material such 

  
 2 

 
as writings, drawings, samples, electronic media, or computer programs, or may be in the nature of unwritten knowledge or know-how. Proprietary Information includes, but is not limited to,
Assigned Inventions, marketing plans, product plans, designs, data, prototypes, specimens, test protocols, laboratory notebooks, business strategies, financial information, forecasts, personnel information, contract information, customer and
supplier lists, and the non-public names and addresses of the Company’s customers and suppliers, their buying and selling habits and special needs. 

9. Confidentiality. At all times, both during my employment and after its termination, I will keep and hold all Proprietary
Information in strict confidence and trust. I will not use or disclose any Proprietary Information without the prior written consent of the Company in each instance, except as may be necessary to perform my duties as an employee of the Company for
the benefit of the Company. Upon termination of my employment with the Company, I will promptly deliver to the Company all documents and materials of any nature pertaining to my work with the Company, and I will not take with me or retain in any
form any documents or materials or copies containing any Proprietary Information. 
 10. Physical Property. All documents,
supplies, equipment and other physical property furnished to me by the Company or produced by me or others in connection with my employment will be and remain the sole property of the Company. I will return to the Company all such items when
requested by the Company, excepting only my personal copies of records relating to my employment or compensation and any personal property I bring with me to the Company and designate as such. Even if the Company does not so request, I will upon
termination of my employment return to the Company all Company property, and I will not take with me or retain any such items. 
 11.
No Breach of Prior Agreements. I represent that my performance of all the terms of this Agreement and my duties as an employee of the Company will not breach any invention assignment, proprietary information, confidentiality,
non-competition, or other agreement with any former employer or other party. I represent that I will not bring with me to the Company or use in the performance of my duties for the Company any documents or materials or intangibles of my own or of a
former employer or third party that are not generally available for use by the public or have not been legally transferred to the Company. 

12. “At Will” Employment. I understand that this Agreement does not constitute a contract of employment or obligate
the Company to employ me for any stated period of time. I understand that I am an “at will” employee of the Company and that my employment can be terminated at any time, with or without notice and with or without cause, for any reason or
for no reason, by either the Company or by me. I acknowledge that any statements or representations to the contrary are ineffective, unless put into a writing signed by the Company. I further acknowledge that my participation in any stock option or
benefit program is not to be construed as any assurance of continuing employment for any particular period of time. 
 13.
Non-Competition; Non-Solicitation. 
 a. Non-Competition. I understand that the Company’s interests in
protecting its investments, goodwill, and technologies make it reasonable for the Company to ask 

  
 3 

 
me to agree that I will not compete with the Company for a reasonable period after the termination of my employment for any reason, whether voluntary or involuntary. Accordingly, and
understanding that the Company’s business is potentially global in scope, I further agree that I will not, during the twelve (12) month period following the termination of my employment (the “Post-Employment
Period”), directly or indirectly, work for or provide service of any kind, as an employee, consultant, director, owner or in any other capacity, to any person or entity (including any business in planning or formation) that is or
intends to be competitive with, or is engaged in the design, development, manufacture, production, marketing, sale or servicing of any product or the provision of any service that relates in any way to the business then being conducted or planned by
the Company and any of its subsidiary or affiliated entities. It will not be deemed to be a violation of this Section 13(a) for me to make or hold either of the following investments: (a) ownership, as a passive investor, of up to two
percent (2%) of any publicly traded company; or (b) an equity interest of up to two percent (2%) in any venture capital fund or other investment vehicle that makes investments in early stage companies so long as I do not participate
in or influence the investment decision process of such fund or vehicle. 
 b. Non-Solicitation of Employees/Consultants.
During my employment with the Company and the Post-Employment Period, I will not directly or indirectly solicit away employees or consultants of the Company for my own benefit or for the benefit of any other person or entity, nor will I encourage or
assist others to do so. I acknowledge and agree that even after the expiration of the Post-Employment Period, I will not solicit (or encourage or assist others to solicit) away any employees or consultants of the Company if, in so doing, I use or
disclose any trade secrets or other Proprietary Information of the Company. 
 c. Non-Solicitation of Suppliers/Customers.
During my employment with the Company and the Post-Employment Period, I will not directly or indirectly solicit or otherwise take away customers or suppliers of the Company or otherwise divert or attempt to divert business away from the Company, nor
will I encourage or assist others to do so. I acknowledge and agree that even after the expiration of the Post-Employment Period, I will not solicit (or encourage or assist others to solicit) any customers or suppliers of the Company if, in so
doing, I use or disclose any trade secrets or other Proprietary Information of the Company. 
 d. Reasonableness. I
acknowledge that the post-employment restrictions on competition and solicitation in this Section 13 are reasonable and necessary in light of the Company’s need to protect its trade secrets and other Proprietary Information and the
goodwill of the Company’s business. 
 14. Use of Name & Likeness. I hereby authorize the Company to use, reuse,
and to grant others the right to use and reuse, my name, photograph, likeness (including caricature), voice, and biographical information, and any reproduction or simulation thereof, in any form of media or technology now known or hereafter
developed, both during and after my employment, for any purposes related to the Company’s business, such as marketing, advertising, credits, and presentations. 

15. Notification. I hereby authorize the Company, during and after the termination of my employment with the Company, to notify
third parties, including, but not limited to, actual or potential customers or employers, of the terms of this Agreement and my responsibilities hereunder. 

  
 4 

 16. Injunctive Relief. I understand that a breach or threatened breach of this
Agreement by me may cause the Company to suffer irreparable harm and that the Company will therefore be entitled to injunctive relief to enforce this Agreement. 

17. Governing Law; Severability. This Agreement is intended to supplement, and not to supersede, any rights the Company may have
in law or equity with respect to the duties of its employees and the protection of its trade secrets. This Agreement will be governed by and construed in accordance with the laws of the State in which I reside at the time of the execution of this
Agreement without giving effect to any principles of conflict of laws that would lead to the application of the laws of another jurisdiction; provided that Section 13(a) hereof will be governed by and construed in accordance with the laws of
the State in which I reside at the time of the enforcement thereof without giving effect to any principles of conflict of laws that would lead to the application of the laws of another jurisdiction. If any provision of this Agreement is invalid,
illegal or unenforceable in any respect, such provision will be enforced to the maximum extent possible, given the fundamental intentions of the parties when entering into this Agreement. To the extent such provision cannot be so enforced, it will
be stricken from this Agreement and the remainder of this Agreement will be enforced as if such invalid, illegal or unenforceable provision had never been contained in this Agreement. 

18. Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered
will be deemed an original, and all of which together will constitute one and the same agreement. 
 19. Entire Agreement.
This Agreement and the documents referred to herein constitute the entire agreement and understanding of the parties with respect to the subject matter of this Agreement, and supersede all prior understandings and agreements, whether oral or
written, between the parties hereto with respect to such subject matter. 
 20. Amendment and Waiver. This Agreement may be
amended only by a written agreement executed by each of the parties to this Agreement. No amendment or waiver of, or modification of any obligation under, this Agreement will be enforceable unless specifically set forth in a writing signed by the
party against which enforcement is sought. A waiver by either party of any of the terms and conditions of this Agreement in any instance will not be deemed or construed to be a waiver of such term or condition with respect to any other instance,
whether prior, concurrent or subsequent. 
 21. Successors and Assigns; Assignment. Except as otherwise provided in this
Agreement, this Agreement, and the rights and obligations of the parties hereunder, will bind and benefit the parties and their respective successors, assigns, heirs, executors, administrators, and legal representatives. The Company may assign any
of its rights and obligations under this Agreement. I understand that I will not be entitled to assign or delegate this Agreement or any of my rights or obligations hereunder, whether voluntarily or by operation of law, except with the prior written
consent of the Company. 

  
 5 

 22. Further Assurances. The parties will execute such further documents and
instruments and take such further actions as may be reasonably necessary to carry out the purposes and intent of this Agreement. Upon termination of my employment with the Company, I will execute and deliver a document or documents in a form
reasonably requested by the Company confirming my agreement to comply with the post-employment obligations contained in this Agreement. 

23. Acknowledgement. I certify and acknowledge that I have carefully read all of the provisions of this Agreement and that I
understand and will fully and faithfully comply with this Agreement. 
 24. Effective Date of Agreement. This Agreement is and
will be effective on and after the first day of my employment by the Company, which is August 18, 2014 (the “Effective Date”). 
  

							
	Imperva, Inc.:	 		 	Employee:
				
	By:	 	 /s/ Frank Slootman
	 		 	 /s/ Anthony Bettencourt

		 		 		 	Signature
				
	Name:	 	 Frank Slootman
	 		 	 Anthony Bettencourt

		 		 		 	Name (Please Print)
				
	Title:	 	 Chairman of the Compensation Committee
	 		 	

  
 6 

 Exhibit A 

LIST OF EXCLUDED INVENTIONS UNDER SECTION 4 
  

					
	 Title
	 	 Date
	 	 Identifying Number

or Brief Description

		 		 	
		 		 	
		 		 	

          No inventions, improvements, or original works of authorship 

         Additional sheets attached 
  

			
	Signature of Employee:	 	 /s/ Anthony Bettencourt

 

			
	Print Name of Employee:	 	 /s/ Anthony Bettencourt

 

			
	Date:	 	 8-13-14

 Exhibit B 

CALFORNIA LABOR CODE 2870 NOTICE: 

California Labor Code Section 2870 provides as follows: 

Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her
rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade secret information except for those
inventions that either: (1) relate at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or (2) result from any
work performed by the employee for the employer. To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be assigned under California Labor Code
Section 2870(a), the provision is against the public policy of this state and is unenforceable.EX-10.5

 Exhibit 10.5 

IMPERVA, INC. 
 NOTICE OF
INDUCEMENT OPTION GRANT 
 Imperva, Inc. has granted you (“Participant”) an Option to purchase Shares of Common Stock of the
Company (“Shares”), subject to the terms and conditions of this Notice of Inducement Option Grant (the “Notice”) and the Inducement Option Award Agreement (the Notice and the Inducement Option
Agreement, collectively, the “Agreement”). 
  

			
	Participant:	  	 Anthony Bettencourt

		
	Address:	  	  

		
	Date of Grant:	  	 August 20, 2014

		
	Vesting Commencement Date:	  	August 18, 2014
		
	Exercise Price per Share:	  	  

		
	Total Number of Shares:	  	 265,000

		
	Type of Option:	  	Non-Qualified Stock Option
		
	Expiration Date:	  	 August 19, 2024

		
	Post-Termination Exercise Period:	  	 Termination for Cause (as defined in 2(c) of the Agreement) = None

		  	 Voluntary Termination = 3 Months

		  	 Termination without Cause = 3 Months

		  	 Disability = 12 Months

		  	 Death = 12 Months

		
	Vesting Schedule:	  	Subject to the limitations set forth in the Agreement (inclusive of the Notice), the Shares subject to the Option will vest and may be exercised, in whole or in part, in accordance with the following schedule:
		
		  	25% of the Shares subject to the Option will vest and become exercisable on the first anniversary of the Vesting Commencement Date with an additional 6.25% of the Shares subject to the Option vesting each quarter thereafter so long
as Participant has not been Terminated, subject to the terms of the Company’s Change in Control Plan. Fractional vesting will be rounded in accordance with the Company’s standard practices in its equity administration platform.

 Participant acknowledges that the vesting pursuant to this Notice is earned only by continuing service as a Company
employee, director or consultant. Participant also understands that this Notice is subject to the terms and conditions of the Agreement, which is incorporated herein by reference. By signing below or electronically accepting the Agreement,
Participant confirms that he has read and agreed to the terms and conditions of this Agreement (inclusive of the Notice). Participant has had an opportunity to obtain the advice of counsel prior to executing the Notice and fully understands all
provisions of this Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Agreement. Participant further agrees to notify the Company upon
any change in the residence address indicated on the Notice. 
  

									
	PARTICIPANT:	 		 	IMPERVA, INC.
					
	Signature:	 	  
	 		 	By:	 	  

					
	Print Name:	 	  
	 		 	Its:	 	  

					
	Date:	 	  
	 		 	Date:	 	  

 IMPERVA, INC. 

INDUCEMENT STOCK OPTION PLAN AND AGREEMENT 

Participant has been granted an option to purchase Shares (the “Option”), subject to the terms and conditions of the Notice and this
Agreement. 
 1. Vesting Rights. Subject to the applicable provisions of this Agreement, this Option may be exercised, in whole or in part, in
accordance with the schedule set forth in the Notice. In the event Participant’s Termination (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed
or the terms of Participant’s employment agreement, if any), Participant’s right to vest in the Shares subject to the Option will terminate effective as of the date that Participant is no longer actively providing services and will not be
extended by any notice period (e.g., active services would not include any contractual notice period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where Participant is employed or the
terms of Participant’s employment agreement, if any); the Committee shall have the exclusive discretion to determine when Participant is no longer actively providing services for purposes of his Option grant (including whether Participant may
still be considered to be providing services while on an approved leave of absence). 
 2. Termination Period. 

(a) General Rule. Except as provided below, this Option may be exercised for three months after Participant’s Termination with the
Company or any Parent or Subsidiary. In no event shall this Option be exercised later than the Expiration Date set forth in the Notice. 

(b) Death; Disability. Unless provided otherwise in the Notice, upon Participant’s Termination by reason of his Disability or
death, or if a Participant dies within three months of the Termination Date, this Option may be exercised for twelve months, provided that in no event shall this Option be exercised later than the Expiration Date set forth in the Notice. 

(c) Cause. Upon Participant’s Termination for Cause, the Option shall expire on such date of Participant’s Termination Date.
For purposes of this Section 2(c) only, “Cause” means (except as may otherwise be defined in Participant’s employment or services agreement or Award Agreement) (a) the commission of an act of theft,
embezzlement, fraud or dishonesty, (b) a breach of fiduciary duty to the Company or a Parent or Subsidiary, or (c) a failure to materially perform the customary duties of Employee’s employment. 

(d) Measurement Date. In the event of Participant’s Termination (whether or not in breach of local labor laws), Participant’s
right to exercise the Option after Termination, if any, will be measured by the date of termination of Participant’s active services and will not be extended by any notice period mandated under employment laws in the jurisdiction where
Participant is employed or terms of Participant’s employment agreement, if any). 
 3. Grant of Option. 

(a) Basic Terms. The Participant named in the Notice has been granted an Option for the number of Shares set forth in the Notice
at the exercise price per Share set forth in the Notice (the “Exercise Price”). 
 (b) Adjustment of Shares.
If the number of outstanding Shares is changed by a stock dividend, recapitalization, stock split, reverse stock split, subdivision, combination, reclassification or similar change in the capital structure of the Company, without consideration, then
the Exercise Price of and number of Shares subject to this Agreement shall be proportionately adjusted, subject to any required action by the Board or the stockholders of the Company and in compliance with applicable securities laws; provided that
fractions of a Share will not be issued. 
 (c) Modification, Extension or Renewal. The Committee may modify, extend or renew the
Option and authorize the grant of new options in substitution therefor, provided that any such action may not, without the written consent of a Participant, impair any of such Participant’s rights under this Agreement. Subject to the terms of
Section 6(f), by written notice to Participant, the Committee may reduce the Exercise Price of the Option without the Participant’s consent; provided, however, that the Exercise Price may not be reduced below the Fair Market Value on the
date the action is taken to reduce the Exercise Price. 

  
 A-1 

 4. Exercise of Option. 

(a) Right to Exercise. This Option is exercisable during its term in accordance with the Vesting Schedule set forth in the Notice
and the applicable provisions of this Agreement. In the event of Participant’s death, Disability, Termination for Cause or other Termination, the exercisability of the Option is governed by the applicable provisions of this Agreement (inclusive
of the Notice). 
 (b) Method of Exercise. This Option is exercisable by delivery of an exercise notice (the “Exercise
Notice”), which shall state the election to exercise the Option, the number of Shares in respect of which the Option is being exercised (the “Exercised Shares”). The Exercise Notice shall be delivered in person,
by mail, via electronic mail or facsimile or by other authorized method to the Secretary of the Company or other person designated by the Company. The Exercise Notice shall be accompanied by payment of the aggregate Exercise Price as to all
Exercised Shares. This Option shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by such aggregate Exercise Price. 

(c) Securities Law. No Shares shall be issued pursuant to the exercise of this Option unless such issuance and exercise complies with
all relevant provisions of securities law and the requirements of any stock exchange or quotation service upon which the Shares are then listed. Assuming such compliance, for tax purposes the Exercised Shares shall be considered transferred to the
Participant on the date the Option is exercised with respect to such Exercised Shares. 
 (d) Limitations on Exercise. The Committee
may specify a minimum number of Shares that may be purchased on any exercise of the Option, provided that such minimum number will not prevent the Participant from exercising the Option for the full number of Shares for which it is then exercisable.

 5. Method of Payment. Unless provided otherwise by the Company, in its sole discretion, or in the Appendix, payment of the aggregate
Exercise Price shall be by any of the following, or a combination thereof, at the election of the Participant: 
 (a) cash; 

(b) check; 
 (c) by
consideration received by the Company pursuant to a broker-assisted or other cashless exercise program implemented by the Company; or 

(d) other method authorized by the Company. 

6. Restrictions. 
 (a) Non-Transferability. This Option may not be transferred in any manner other than by will or by the laws of descent or distribution or court order and may be exercised during the lifetime of Participant only by
the Participant unless otherwise permitted by the Committee on a case-by-case basis. The terms of this Agreement shall be binding upon the executors, administrators,
heirs, successors and assigns of the Participant. 
 (b) Voting and Dividends. No Participant will have any of the rights of a
stockholder with respect to any Shares until the Shares are issued to the Participant. After Shares are issued to the Participant, the Participant will be a stockholder and have all the rights of a stockholder with respect to such Shares, including
the right to vote and receive all dividends or other distributions made or paid with respect to such Shares. 
 (c) Certificates. All
certificates for Shares will be subject to such stock transfer orders, legends and other restrictions as the Committee may deem necessary or advisable, including restrictions under any applicable federal, state or foreign securities law, or any
rules, regulations and other requirements of the SEC or any stock exchange or automated quotation system upon which the Shares may be listed or quoted. 

(d) Escrow; Pledge of Shares. To enforce any restrictions on a Participant’s Shares, the Committee may require the Participant to
deposit all certificates representing Shares, together with stock powers or other instruments of transfer approved by the Committee, appropriately endorsed in blank, with the Company or an agent designated by the Company to hold in escrow until such
restrictions have lapsed or terminated, and the Committee 

  
 A-2 

 
may cause a legend or legends referencing such restrictions to be placed on the certificates. If Participant is permitted to execute a promissory note as partial or full consideration for the
purchase of Shares under this Agreement, he will be required to pledge and deposit with the Company all or part of the Shares so purchased as collateral to secure the payment of the Participant’s obligation to the Company under the promissory
note; provided, however, that the Committee may require or accept other or additional forms of collateral to secure the payment of such obligation and, in any event, the Company will have full recourse against the Participant under the promissory
note notwithstanding any pledge of the Participant’s Shares or other collateral. In connection with any pledge of the Shares, the Participant will be required to execute and deliver a written pledge agreement in such form as the Committee will
from time to time approve. The Shares purchased with the promissory note may be released from the pledge on a pro rata basis as the promissory note is paid. 

(e) Insider Trading Policy. Participant shall comply with any policy adopted by the Company from time to time covering transactions in
the Company’s securities by employees, officers and/or directors of the Company. 
 (f) Repricing; Exchange and Buyout of
Awards. Without prior stockholder approval, the Committee may (a) reprice the Option (and where such repricing is a reduction in the Exercise Price of outstanding Options, the consent of Participant is not required provided written notice
is provided to him), and (b) with the consent of the Participants (unless not required pursuant to Section 3(c) of this Agreement), pay cash or issue new awards in exchange for the surrender and cancellation of the Option, or any
portion thereof. 
 7. Term of Option. This Option shall in any event expire on the expiration date set forth in the Notice, which date is
10 years after the Date of Grant. 
 8. Tax Obligations. Participant acknowledges that, regardless of any action taken by the Company or,
if different, Participant’s employer (the “Employer”), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax related items related to
Participant’s Option and legally applicable to Participant (“Tax-Related Items”), is and remains Participant’s responsibility and may exceed the amount actually withheld by
the Company or the Employer. Participant further acknowledges that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in
connection with any aspect of the Option, including, but not limited to, the grant, vesting or exercise of the Option, the subsequent sale of Shares acquired pursuant to such exercise and the receipt of any dividends; and (ii) do not commit to
and are under no obligation to structure the terms of the grant or any aspect of the Option to reduce or eliminate Participant’s liability for Tax-Related Items or achieve any particular tax result.
Further, if Participant is subject to Tax-Related Items in more than one jurisdiction between the Date of Grant and the date of any relevant taxable or tax withholding event, as applicable, Participant
acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. 

Prior to the relevant taxable or tax withholding event, as applicable, Participant agrees to make adequate arrangements satisfactory to the
Company and/or the Employer to satisfy all Tax-Related Items. In this regard, Participant authorizes the Company and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations
with regard to all Tax-Related Items by one or a combination of the following: 
 (a) withholding
from Participant’s wages or other cash compensation paid to Participant by the Company and/or the Employer; or 
 (b) withholding from
proceeds of the sale of Shares acquired at exercise of the Option either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant’s behalf pursuant to this authorization) without further consent. 

Depending on the withholding method, the Company may withhold or account for Tax-Related Items by
considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates, in which case Participant will receive a refund of any over-withheld
amount in cash and will have no entitlement to the Common Stock equivalent. 
 Finally, Participant agrees to pay to the Company or the
Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of this Agreement that cannot be satisfied by the means previously described.
The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if Participant fails to comply with his obligations in connection with the Tax-Related Items. 

  
 A-3 

 9. Acknowledgement of Nature of the Grant. The Company and Participant agree that the Option is
granted under and governed by this Agreement. Participant acknowledges receipt of a copy of the Option prospectus, represents that Participant has carefully read and is familiar with the Option and hereby accepts the Option subject to all of the
terms and conditions set forth in this Agreement. Participant further acknowledges, understands and agrees that: 
 (a) the grant of the
Option is voluntary and does not create any contractual or other right to receive future grants of Options, or benefits in lieu of Options; 

(b) the Option grant shall not create a right to employment or be interpreted as forming an employment or service contract with the Company,
the Employer or any Parent, Subsidiary or affiliate of the Company, and shall not interfere with the ability of the Company, the Employer or any Parent, Subsidiary or affiliate of the Company, as applicable, to terminate Participant’s
employment or service relationship (if any); 
 (c) Participant is voluntarily accepting this Option; 

(d) the Option and any Shares acquired hereunder are not intended to replace any pension rights or compensation; 

(e) the Option and any Shares acquired hereunder and the income and value of same, are not part of normal or expected compensation for
purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses,
long-service awards, pension or retirement or welfare benefits or similar payments; 
 (f) the
future value of the Shares underlying the Option is unknown, indeterminable, and cannot be predicted with certainty; 
 (g) if the
underlying Shares do not increase in value, the Option will have no value; 
 (h) if Participant exercises the Option and acquires Shares,
the value of such Shares of may increase or decrease in value, even below the Exercise Price; 
 (i) no claim or entitlement to compensation
or damages shall arise from forfeiture of the Option resulting from Participant’s Termination (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed
or the terms of Participant’s employment agreement, if any), and in consideration of the grant of the Option to which Participant is otherwise not entitled, Participant irrevocably agrees never to institute any claim against the Company, its
Parent, or any of its Subsidiaries or affiliates or the Employer, waives his ability, if any, to bring any such claim, and releases the Company, its Parent, Subsidiaries and affiliates and the Employer from any such claim; if, notwithstanding the
foregoing, any such claim is allowed by a court of competent jurisdiction, then, Participant shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal
of such claim; and 
 (j) unless otherwise provided by the Company in its discretion, the Option and the benefits evidenced by this
Agreement do not create any entitlement to have the Option or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any Corporate Transaction affecting the Shares;

 10. No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any
recommendations regarding this Option or Participant’s acquisition or sale of the underlying Shares. Participant is hereby advised to consult with his own personal tax, legal and financial advisors regarding this Option before taking any
action. 
 11. Data Privacy. Participant hereby explicitly and unambiguously consents to the collection, use and transfer,
in electronic or other form, of Participant’s personal data as described in this Agreement and any other Option grant materials by and among, as applicable, the Employer, the Company and its Parent, Subsidiaries and affiliates for the exclusive
purpose of implementing, administering and managing this Agreement and Participant’s Option. 

  
 A-4 

 Participant understands that the Company and the Employer may hold certain personal
information about Participant, including, but not limited to, Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Shares or
directorships held in the Company, details of all Options or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor (“Data”), for the exclusive purpose of implementing,
administering and managing this Agreement. 
 Participant understands that Data will be transferred to a designated broker or
such other stock administrator as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Option and this Agreement. Participant understands that the recipients of
the Data may be located in the United States or elsewhere, and that the recipient’s country (e.g., the United States) may have different data privacy laws and protections than Participant’s country. Participant understands that if he or
she resides outside the United States, he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his local human resources representative. Participant authorizes the Company, its designed broker
and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Option to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole
purposes of implementing, administering and managing Participant’s Option and this Agreement. Participant understands that Data will be held only as long as is necessary to implement, administer and manage Participant’s Option and this
Agreement. Participant understands that if he or she resides outside the United States, he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or
refuse or withdraw the consents herein, in any case without cost, by contacting in writing his local human resources representative. Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis. If
Participant does not consent, or if Participant later seeks to revoke his consent, his employment status or service and career with the Employer will not be adversely affected; the only adverse consequence of refusing or withdrawing
Participant’s consent is that the Company would not be able to grant or maintain the Option. Therefore, Participant understands that refusing or withdrawing his consent may affect Participant’s Option. For more information on the
consequences of Participant’s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his local human resources representative. 

12. Entire Agreement; Enforcement of Rights. This Agreement (inclusive of the Notice) constitutes the entire agreement and understanding of the
parties relating to the subject matter herein and supersede all prior discussions between the parties. Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded. No modification of or amendment
to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing and signed by the parties to this Agreement. Participant acknowledges that a waiver by the Company of breach of any provision of this
Agreement shall not operate or be construed as a waiver of any other provision of this Agreement or of any subsequent breach by Participant. 
 13.
Compliance with Laws and Regulations. Notwithstanding any other provision hereunder, unless there is an available exemption from any registration, qualification or other legal requirement applicable to the Shares, the Company shall not be
required to deliver any Shares issuable upon exercise of the Option prior to the completion of any registration or qualification of the Shares under any local, state, federal or foreign securities or exchange control law or under rulings or
regulations of the U.S. SEC or of any other governmental regulatory body, or prior to obtaining any approval or other clearance from any local, state, federal or foreign governmental agency, which registration, qualification or approval the Company
shall, in its absolute discretion, deem necessary or advisable. Participant understands that the Company is under no obligation to register or qualify the Shares with the SEC or any state or foreign securities commission or to seek approval or
clearance from any governmental authority for the issuance or sale of the Shares. Further, Participant agrees that the Company shall have unilateral authority to amend the Agreement without Participant’s consent to the extent necessary to
comply with securities or other laws applicable to issuance of Shares. 
 14. Governing Law and Venue; Severability. If one or more provisions
of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then
(i) such provision shall be excluded from this Agreement, (ii) the balance of this Agreement shall be interpreted as if such 

  
 A-5 

 
provision were so excluded and (iii) the balance of this Agreement shall be enforceable in accordance with its terms. This Agreement and all acts and transactions pursuant hereto and the
rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of Delaware, without giving effect to principles of conflicts of law. For purposes of any action, lawsuit or other
proceedings brought to enforce this Agreement, relating to it, or arising from it, the parties hereby submit to and consent to the sole and exclusive jurisdiction of the courts of San Mateo County, California, or the federal courts for the United
States for the Northern District of California, and no other courts, where this grant is made and/or to be performed. 
 15. Electronic Delivery and
Acceptance. The Company may, in its sole discretion, decide to deliver any documents related to this Agreement by electronic means. Participant hereby consents to receive such documents by electronic delivery and agrees to the administration
of this Agreement on-line or on an electronic system established and maintained by the Company or a third party designated by the Company. 

16. Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Option and on any Shares acquired upon
exercise of the Option, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the
foregoing. 
 17. Administration. Subject to the general purposes, terms and conditions of this Agreement, and to the direction of the Board,
the Committee will have full power to implement and carry out this Agreement, and will have the authority to (a) construe and interpret this Agreement, (b) prescribe, amend and rescind rules and regulations relating to this Agreement,
(c) determine the Fair Market Value in good faith, if necessary, (d) determine whether this Option will be granted singly, in combination with, in tandem with, in replacement of, or as alternatives to, other awards or incentive or
compensation plans of the Company or any Parent or Subsidiary of the Company, (e) grant waivers of conditions hereunder, (f) correct any defect, supply any omission or reconcile any inconsistency hereunder, (g) determine whether the
Option is vested, (h) determine the terms and conditions of any, and to institute any Exchange Program, and (i) make all other determinations necessary or advisable for the administration of this Agreement. Any determination made by the
Committee with respect to this Option or Agreement shall be made in its sole discretion on the Date of Grant or, unless in contravention of any express term of this Agreement, at any later time, and such determination shall be final and binding on
the Company and all persons having an interest in the Option. Any dispute regarding the interpretation of this Agreement shall be submitted by the Participant or Company to the Committee for review. The resolution of such a dispute by the Committee
shall be final and binding on the Company and the Participant. 
 18. Corporate Transactions. In the event of a Corporate Transaction, the
Option may be assumed or replaced by the successor corporation, which assumption or replacement shall be binding on Participant. In the alternative, the successor corporation may substitute an equivalent award or provide substantially similar
consideration to Participant as was provided to stockholders (after taking into account the existing provisions of the Option). The successor corporation may also issue, in place of outstanding Shares of the Company held by the Participant,
substantially similar shares or other property subject to repurchase restrictions no less favorable to the Participant. In the event such successor or acquiring corporation (if any) refuses to assume, convert, replace or substitute the Option, as
provided above, pursuant to a Corporate Transaction, then notwithstanding any other provision in this Agreement to the contrary, such Option will expire on such transaction at such time and on such conditions as the Board will determine; the Board
(or, the Committee, if so designated by the Board) may, in its sole discretion, accelerate the vesting of the Shares subject to the Option in connection with a Corporate Transaction. In addition, in the event such successor or acquiring corporation
(if any) refuses to assume, convert, replace or substitute this Option, as provided above, pursuant to a Corporate Transaction, the Committee will notify the Participant in writing or electronically that such Option will be exercisable for a period
of time determined by the Committee in its sole discretion, and such Option will terminate upon the expiration of such period. 
 19.
Definitions. In addition to the terms defined elsewhere in the Agreement (inclusive of the Notice), the following definitions shall apply: 

(a) “Board” means the Board of Directors of the Company. 

(b) “Common Stock” means the common stock of the Company. 

(c) “Committee” means the Compensation Committee of the Board or those persons to whom administration of this
Agreement, or part of this Agreement, has been delegated as permitted by law. 

  
 A-6 

 (d) “Code” means the United States Internal Revenue Code of 1986, as
amended, and the regulations promulgated thereunder. 
 (e) “Corporate Transaction” means the occurrence of any of
the following events: (a) any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) or “group” (two or more
persons acting as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding, or disposing of the applicable securities referred to herein) becomes the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then-outstanding voting securities; (b) the consummation of the sale or other disposition by the Company of all or substantially all of the Company’s assets; (c) the consummation of a merger,
reorganization, consolidation or similar transaction or series of related transactions of the Company with any other corporation, other than a merger, reorganization, consolidation or similar transaction (or series of related transactions) which
would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least a
majority of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger, reorganization, consolidation or similar transaction (or series of related
transactions), or (d) any other transaction which qualifies as a “corporate transaction” under Section 424(a) of the Code wherein the stockholders of the Company give up all of their equity interest in the Company (except
for the acquisition, sale or transfer of all or substantially all of the outstanding shares of the Company). 
 (f)
“Disability” means total and permanent disability as defined in Section 22(e)(3) of the Code. 
 (g)
“Exchange Program” means a program pursuant to which outstanding awards are surrendered, cancelled or exchanged for cash, the same type of awards or a different award (or combination thereof). 

(h) “Fair Market Value” means, as of any date, the value of a share of the Company’s Common Stock determined as
follows: (i) if such Common Stock is publicly traded and is then listed on a national securities exchange, its closing price on the date of determination on the principal national securities exchange on which the Common Stock is listed or
admitted to trading as reported in The Wall Street Journal or such other source as the Board or the Committee deems reliable; (ii) if such Common Stock is publicly traded but is neither listed nor admitted to trading on a national
securities exchange, the average of the closing bid and asked prices on the date of determination as reported in The Wall Street Journal or such other source as the Board or the Committee deems reliable; or (iii) if none of the foregoing
is applicable, by the Board or the Committee in good faith. 
 (i) “Parent” means any corporation (other than the
Company) in an unbroken chain of corporations ending with the Company if each of such corporations other than the Company owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the
other corporations in such chain. 
 (j) “SEC” means the United States Securities and Exchange Commission. 

(k) “Subsidiary” means any corporation (other than the Company) in an unbroken chain of corporations beginning with
the Company if each of the corporations other than the last corporation in the unbroken chain owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such
chain. 
 (l) “Termination” or “Terminated” means that the Participant has for any reason
ceased to provide services as an employee, officer, director, consultant, independent contractor or advisor to the Company or a Parent or Subsidiary of the Company. Participant will not be deemed to have ceased to provide services in the case of
(i) sick leave, (ii) military leave, or (iii) any other leave of absence approved by the Committee; provided, that such leave is for a period of not more than 90 days, unless reemployment upon the expiration of such leave is
guaranteed by contract or statute or unless provided otherwise pursuant to formal policy adopted from time to time by the Company and issued and promulgated to employees in writing. In the case of any employee on an approved leave of absence, the
Committee may make such provisions respecting suspension of vesting of the Shares subject to the Option while on leave from the employ of the Company or a Parent or Subsidiary of the Company as it may deem appropriate, except that in no event may an
Option be exercised after the expiration of the term set forth in the Notice. The Committee will have sole discretion to determine whether a Participant has ceased to provide services and the effective date on which the Participant ceased to provide
services (the “Termination Date”). 

  
 A-7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00234-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00234-of-00352.parquet"}]]